ULURU Inc., a pharmaceutical company, engages in the research, development, and commercialization of wound care and muco-adhesive film products in the United States and internationally. The companys products are based on patented Nanoflex and OraDisc drug delivery technologies. Its products include Altrazeal, a transforming powder dressing for the treatment of various wounds, such as partial thickness burns, donor sites, and abrasions, as well as surgical, acute, and chronic wounds; Aphthasol and Aptheal for the treatment of canker sores; OraDisc A for the treatment of oral conditions, which rely upon the use of medications formulated as gels and pastes that are applied to lesions in the mouth; OraDisc B for the treatment and management of oral pain; and Residerm A gel-Zindaclin for the treatment of acne. The company is based in Addison, Texas.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• No BuyIns.Net Alerts Available for ULU